Intraneuronal accumulation of NFT made of hyperphosphorylated tau protein is directly correlated with cognitive decline in AD and other primary tauopathies, making it crucial to find neuroprotective pathways that might prevent or reduce the hyperphosphorylation of tau. Here, MAPT is linked to Alzheimer disease.